arrow
返回
H

Hakan Harputluoğlu

inonu university

27H指数
151论文数
9.5K被引数
收录论文 25
发表时间
ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK plus non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)ALINA:在接受了手术切除的ALK阳性非小细胞肺癌(NSCLC)患者中,接受辅助阿来替尼治疗与接受化疗的患者的探索性生物标志物分析
err2024-09-01
err4
PREAI
errSolomon, B. J.; Wu, Y-L.; Dziadziuszko, R.; Barlesi, F.; Nishio, M.; Ahn, J. S.; Horinouchi, H.; Hochmair, M. J.; de Marinis, F.; Migliorino, M. R.; Kurochkin, A.; Harputluoglu, H.; Planchard, D.; Korphaisarn, K.; Han, J-Y.; Lohmann, T.; Gavaldon, A. Cardona; Archer, V. R.; Nowicka, M.; Noe, J.
err分享
err收藏
Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study
err2022-06-01
err1
errOAAI
errArtac, M.; Cubukcu, E.; Bozkurt, O.; Bilici, A.; Celik, S.; Ozcelik, M.; Oven, B.; Simsek, E.; Geredeli, C.; Karaca, M.; Cil, T.; Harputluoglu, H.; Sendur, M.; Turk, H.; Kefeli, U.; Alacacioglu, A.; Tural, D.; Sakin, A.; Karadurmus, N.; Cevik, D.; Dane, F.; Gumus, M.
err分享
err收藏
First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis
err2022-06-01
err0
errOAAI
errIsikdogan, A.; Turk, H.; Bilir, C.; Sendur, M.; Karabulut, B.; Artac, M.; Cicin, I.; Geredeli, C.; Alacacioglu, A.; Kefeli, U.; Harputluoglu, H.; Bozkurt, O.; Cubukcu, E.; Tural, D.; Sakin, A.; Cil, T.; Dane, F.; Cevik, D.; Arslan, C.; Karadurmus, N.; Gumus, M.; Yalcin, S.
err分享
err收藏
Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study
err2021-07-01
err0
PREAI
errArslan, C.; Kefeli, U.; Yildirim, E.; Isikdogan, A.; Karadurmus, N.; Karabulut, B.; Cicin, I.; Cubukcu, E.; Bilir, C.; Ozcelik, M.; Cil, T.; Celik, S.; Bozkurt, O.; Harputluoglu, H.; Oven, B.; Geredeli, C.; Tural, D.; Sakin, A.; Cevik, D.; Gumus, M.; Yalcin, S.
err分享
err收藏
The effect of the use of complex molecular profiling in advanced solid organ tumours on clinical decision: Turkey molecular profiling in advanced cancers trial (TUMPACT)
err2020-09-01
err0
errOAAI
errOlmez, O. F.; Bilici, A.; Er, O.; Sevinc, A.; Akman, T.; Uslu, R.; Mandel, N. M.; Yalcin, S.; Teomete, M.; Gorumlu, G.; Demir, A.; Namal, E.; Alici, S.; Selcukbiricik, F.; Bavbek, S.; Paksoy, F.; Basaran, G.; Ozer, L.; Sener, N.; Harputluoglu, H.
err分享
err收藏
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
errLANCET
IF88.5
err2017-11-01
err135
errOAAI
errPetrylak, Daniel P.; de Wit, Ronald; Chi, Kim N.; Drakaki, Alexandra; Sternberg, Cora N.; Nishiyama, Hiroyuki; Castellano, Daniel; Hussain, Syed; Flechon, Aude; Bamias, Aristotelis; Yu, Evan Y.; van der Heijden, Michiel S.; Matsubara, Nobuaki; Alekseev, Boris; Necchi, Andrea; Geczi, Lajos; Ou, Yen-Chuan; Coskun, Hasan Senol; Su, Wen-Pin; Hegemann, Miriam; Percent, Ivor J.; Lee, Jae-Lyun; Tucci, Marcello; Semenov, Andrey; Laestadius, Fredrik; Peer, Avivit; Tortora, Giampaolo; Safina, Sufia; Garcia del Muro, Xavier; Rodriguez-Vida, Alejo; Cicin, Irfan; Harputluoglu, Hakan; Widau, Ryan C.; Liepa, Astra M.; Walgren, Richard A.; Hamid, Oday; Zimmermann, Annamaria H.; Bell-McGuinn, Katherine M.; Powles, Thomas
err分享
err收藏
Is lymph node ratio (LNR) having additional contribution for predict prognosis on pathologic lymph node staging in node -positive breast cancer patients?
err2016-02-15
err0
PREAI
errKaplan, M. A.; Odabasi, H.; Ozdemir, N.; Harputluoglu, H.; Aliustaoglu, M.; Berk, V.; Gunaydin, Y.; Uncu, D.; Elkiran, T.; Aydin, D.; Isikdogan, A.
err分享
err收藏
Breast cancer subtypes and outcomes of central nervous system metastases乳腺癌亚型与中枢神经系统转移的预后
errBREAST
IF7.9
err2011-12-01
err49
errOAAI
errArslan, Ulku Y.; Oksuzoglu, Berna; Aksoy, Sercan; Harputluoglu, Hakan; Turker, Ibrahim; Ozisik, Yavuz; Dizdar, Omer; Altundag, Kadri; Alkis, Necati; Zengin, Nurullah
err分享
err收藏
err分享
err收藏
Prognostic factors in breast cancer patients with brain metastases
err2007-12-14
err1
PREAI
errHarputluoglu, Hakan; Dizdar, Omer; Altundag, Kadri
err分享
err收藏
Prognostic factors in long-term breast cancer survivors with brain metastases
err2007-12-04
err1
PREAI
errHarputluoglu, Hakan; Kara, Atilla; Dizdar, Omer; Surmeli, Zeki G.; Altundag, Kadri
err分享
err收藏
Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management
err2007-12-01
err1
PREAI
errAltundag, Kadri; Dede, Didem; Harputluoglu, Hakan; Gullu, Ibrahim
err分享
err收藏
Bone mineral density in breast cancer patients with estrogen receptor-negative tumor
err2007-11-01
err0
PREAI
errDede, Didem S.; Dizdar, Omer; Harputluoglu, Hakan; Altundag, Kadri
err分享
err收藏
Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance
err2007-09-14
err7
PREAI
errDizdar, Omer; Erman, Mustafa; Cankurtaran, Mustafa; Halil, Meltem; Ulger, Zekeriya; Yavuz, Burcu Balam; Ariogul, Servet; Pinar, Ash; Harputluoglu, Hakan; Kars, Ayse; Celik, Ismail
err分享
err收藏
Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors
err2007-09-13
err4
PREAI
errHarputluoglu, Hakan; Dizdar, Omer; Karaahmet, Fatih; Altundag, Kadri
err分享
err收藏
Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer
err2007-07-06
err0
PREAI
errBulut, Nilufer; Harputluoglu, Hakan; Dizdar, Omer; Altundag, Kadri
err分享
err收藏